Dec 9 (Reuters) - Biogen Inc BIIB.O :
* Biogen and AbbVie receive Health Canada approval of once-monthly Zinbryta (daclizumab beta) for multiple sclerosis
* Biogen Inc - Health Canada has approved Zinbryta for adult patients with active relapsing remitting multiple sclerosis Source text for Eikon: ID:nCNWqWn8ta Further company coverage: BIIB.O